These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 512881)

  • 1. Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate II: Parameter determinations.
    Yu CD; Fox JL; Ho NF; Higuchi WI
    J Pharm Sci; 1979 Nov; 68(11):1347-57. PubMed ID: 512881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development.
    Yu CD; Fox JL; Ho NF; Higuchi WI
    J Pharm Sci; 1979 Nov; 68(11):1341-6. PubMed ID: 512880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical model evaluation of topical prodrug delivery--simultaneous transport and bioconversion of vidarabine-5'-valerate V: Mechanistic analysis of influence of nonhomogeneous enzyme distributions in hairless mouse skin.
    Yu CD; Gordon NA; Fox JL; Higuchi WI; Ho NF
    J Pharm Sci; 1980 Jul; 69(7):775-80. PubMed ID: 7391938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical model evaluation of topical prodrug delivery--simultaneous transport and bioconversion of vidarabine-5'-valerate III: Permeability differences of vidarabine and n-pentanol in components of hairless mouse skin.
    Yu CD; Higuchi WI; Ho NF; Fox JL; Flynn GL
    J Pharm Sci; 1980 Jul; 69(7):770-2. PubMed ID: 7391936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical model evaluation of topical prodrug delivery--simultaneous transport and bioconversion of vidarabine-5'-valerate IV: Distribution of esterase and deaminase enzymes in hairless mouse skin.
    Yu CD; Fox JL; Higuchi WI; Ho NF
    J Pharm Sci; 1980 Jul; 69(7):772-5. PubMed ID: 7391937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical vaginal drug delivery I: effect of the estrous cycle on vaginal membrane permeability and diffusivity of vidarabine in mice.
    Hsu CC; Park JY; Ho NF; Higuchi WI; Fox JL
    J Pharm Sci; 1983 Jun; 72(6):674-80. PubMed ID: 6683757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin after its topical application: the effect of enzyme distribution in skin.
    Sugibayashi K; Hayashi T; Morimoto Y
    J Control Release; 1999 Nov; 62(1-2):201-8. PubMed ID: 10518652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of enzyme distribution and diffusion on permeation profile of prodrug through viable skin: theoretical aspects for several steady-state fluxes in two transport directions.
    Hatanaka T; Rittirod T; Katayama K; Koizumi T
    Biol Pharm Bull; 1999 Jun; 22(6):623-6. PubMed ID: 10408238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotating-disk method for determining cutaneous metabolism.
    Leung LC; Ando HY
    J Pharm Sci; 1979 May; 68(5):571-4. PubMed ID: 430492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local topical delivery of drugs: a model incorporating simultaneous diffusion and metabolic interconversion between drug and a single metabolite in the skin.
    Stehle RG; Ho NF; Barsuhn CL; Stefanski KJ
    J Theor Biol; 1989 May; 138(1):1-15. PubMed ID: 2626062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous effect of azone pretreatment on permeability of antivirotic Ara-ADA through hairless mouse skin].
    Xu HN
    Yao Xue Xue Bao; 1989; 24(4):290-4. PubMed ID: 2816390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
    He N; Warner KS; Higuchi WI; Li SK
    Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model studies of epidermal permeability.
    Kim YH; Ghanem AH; Higuchi WI
    Semin Dermatol; 1992 Jun; 11(2):145-56. PubMed ID: 1498018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
    Tirucherai GS; Dias C; Mitra AK
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum transepidermal flux for similar size phenolic compounds is enhanced by solvent uptake into the skin.
    Zhang Q; Li P; Roberts MS
    J Control Release; 2011 Aug; 154(1):50-7. PubMed ID: 21549777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative fluorometric study of benzo(a)pyrene and aza-aromatic hydrocarbon penetration and metabolism kinetics in the skin of hairless mice.
    Lopp A; Kirso U; Jacquignon P; Ricci A; Alunni Bistocchi G; De Meo G; Pedini M; Binaglia L
    Cancer Biochem Biophys; 1991 Nov; 12(3):167-76. PubMed ID: 1844909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of 9-beta-D-arabinofuranosyladenine (ara-A) transdermal delivery system for animal studies: regulation of drug concentration in vivo.
    Komada F; Imanidis G; Miyajima M; Okano T; Durrani MJ; Higuchi WI; Kim SW; Shannon WM; Baker DC
    J Pharm Sci; 1991 Oct; 80(10):935-41. PubMed ID: 1784002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved method for determining partition and diffusion coefficients in human dermis.
    Ibrahim R; Kasting GB
    J Pharm Sci; 2010 Dec; 99(12):4928-39. PubMed ID: 20533434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase.
    Lipper RA; Machkovech SM; Drach JC; Higuchi WI
    Mol Pharmacol; 1978 Mar; 14(2):366-9. PubMed ID: 642934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.